CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 112068-112358 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T683","span":{"begin":0,"end":290},"obj":"Sentence"},{"id":"T31411","span":{"begin":0,"end":290},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The study (D153P501) was designed to determine the efficacy of CAIV-T in a diverse Asian population of children age 12-36 months against culture-confirmed influenza illness, to assess the efficacy over serial influenza seasons, and to investigate the impact of CAIV-T on acute otitis media."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T88","span":{"begin":0,"end":290},"obj":"Sentence"}],"text":"The study (D153P501) was designed to determine the efficacy of CAIV-T in a diverse Asian population of children age 12-36 months against culture-confirmed influenza illness, to assess the efficacy over serial influenza seasons, and to investigate the impact of CAIV-T on acute otitis media."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T624","span":{"begin":21,"end":24},"obj":"Disease"},{"id":"T625","span":{"begin":155,"end":164},"obj":"Disease"},{"id":"T626","span":{"begin":209,"end":218},"obj":"Disease"},{"id":"T627","span":{"begin":277,"end":289},"obj":"Disease"},{"id":"T628","span":{"begin":277,"end":283},"obj":"Disease"}],"attributes":[{"id":"A624","pred":"mondo_id","subj":"T624","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A625","pred":"mondo_id","subj":"T625","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A626","pred":"mondo_id","subj":"T626","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A627","pred":"mondo_id","subj":"T627","obj":"http://purl.obolibrary.org/obo/MONDO_0024330"},{"id":"A628","pred":"mondo_id","subj":"T628","obj":"http://purl.obolibrary.org/obo/MONDO_0021666"}],"text":"The study (D153P501) was designed to determine the efficacy of CAIV-T in a diverse Asian population of children age 12-36 months against culture-confirmed influenza illness, to assess the efficacy over serial influenza seasons, and to investigate the impact of CAIV-T on acute otitis media."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T163","span":{"begin":271,"end":289},"obj":"Phenotype"}],"attributes":[{"id":"A163","pred":"hp_id","subj":"T163","obj":"http://purl.obolibrary.org/obo/HP_0000371"}],"text":"The study (D153P501) was designed to determine the efficacy of CAIV-T in a diverse Asian population of children age 12-36 months against culture-confirmed influenza illness, to assess the efficacy over serial influenza seasons, and to investigate the impact of CAIV-T on acute otitis media."}